Abiopharma

New Form D - QHSLab, Inc. Filed: 2026-01-06 AccNo: 0001493152-26-000529 Size: 6 KB

Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon

New Form 25-NSE - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001354457-26-000008 Size: 3 KB

(99% Positive) QHSLab, Inc. (USAQ) Reports Q1 2026 Financial Results

QHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor Session

📋 Borgeson Blake (Director) plans to sell 220K shares of RECURSION PHARMACEUTICALS, INC. (at $4.36 each, total $959K) Filed: Jan 06, 2026 | ID: 000126

Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dark Blue Therapeutics acquired by Amgen for up to $840 million

(85% Positive) DAY ONE BIOPHARMACEUTICALS, INC. (DAWN) Announces Business Combination

(99% Neutral) MERSANA THERAPEUTICS, INC. (MRSN) Announces Business Combination

New Form SC 14D9/A - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001124 Size: 22 KB

Illumina, Inc. - Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis

Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative

New Form 424B3 - SONIDA SENIOR LIVING, INC. Filed: 2026-01-06 AccNo: 0001193125-26-003544 Size: 6 MB

New Form SC TO-T/A - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001116 Size: 54 KB